Loading clinical trials...
Loading clinical trials...
A PILOT, EXPLORATIVE STUDY TO IDENTIFY CONTRAST-ENHANCED ULTRASOUND (CE-US) PATTERNS THAT CHARACTERIZE ACUTE ALLOGRAFT REJECTION AND OTHER CAUSES OF ACUTE ALLOGRAFT DYSFUNCTION IN RENAL TRANSPLANT RECIPIENTS
Conditions
Interventions
Contrast-enhanced ultrasound (CE-US)
SonoVue
Locations
1
Italy
Unità di Nefrologia e Dialisi - A.O. Papa Giovanni XXIII
Bergamo, Bergamo, Italy
Start Date
April 1, 2011
Primary Completion Date
October 1, 2012
Completion Date
September 1, 2013
Last Updated
October 29, 2013
NCT07294183
NCT05086003
NCT03478215
NCT03504241
NCT04774575
NCT05208788
Lead Sponsor
Mario Negri Institute for Pharmacological Research
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions